Norway· NO-ID_0BAAE8C3-D75A-4562-B3CB-A87CA6CB39BC
Mercilon 28
A desogestrel and ethinylestradiol product containing desogestrel + ethinylestradiol + lactose monohydrate, registered in Norway by N.V. Organon - Kloosterstraat. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Desogestrel and ethinylestradiol is registered in 11 of 19 countries.
Countries holding a registration under ATC G03AA09 (desogestrel and ethinylestradiol), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Desogestrel and ethinylestradiol · ATC G03AA09
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Desogestrel + Ethinylestradiol + Lactose Monohydrate
- Manufacturer
- N.V. Organon - Kloosterstraat
- Country
- Norway (NO)
- ATC code
- G03AA09
- ATC class
- Desogestrel and ethinylestradiol
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_0BAAE8C3-D75A-4562-B3CB-A87CA6CB39BC
- no_varenummer5938303 x 28NOK 134
- gtin840164506693
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
494 interactions on record for desogestrel and ethinylestradiol.
Graded by severity as the source publishes them — 40 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Desogestrel and ethinylestradiol · interactions on record
494 records
- 40 severe
- 372 moderate
- 49 minor
Most severe, free to view
- Tranexamic acidB02AA02severe
- HeminB06AB01severe
- BosentanC02KX01severe
- GriseofulvinD01AA08severe
33 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Desogestrel and ethinylestradiol in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Belgium · Lumivela Continu 20, Lumivela Continu 30
- Czechia · Bellvalyn
- Spain · Mariona Diario
- Finland · Lumivela
- France · Varnoline Continu
- Luxembourg · Lumivela Continu
- Netherlands · Bryoronna 28, Lumivela
- Sweden · Desolett 28, Mercilon 28
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/74558540-2d9b-4b29-b38b-6bd8e1180b7d GET /v1/drugs/74558540-2d9b-4b29-b38b-6bd8e1180b7d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablett",
"source": "fest",
"status": "A",
"atc_name": "Desogestrel og etinyløstradiol",
"merkevare_id": "ID_0BAAE8C3-D75A-4562-B3CB-A87CA6CB39BC",
"name_form_strength": "Mercilon 28 tab 150 mikrog/20 mikrog",
"prescription_group": "C"
}See everything about desogestrel and ethinylestradiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.